Company: INMB
Filing Date: 2025-04-21
Form Type: DEF 14A
Source: 0001213900-25-033742
Chunk: 62

Company: Inmune Bio, Inc.
Filing Date: 2025-04-21
Form: DEF 14A
Chunk 62
---
50,000shares of Stock subject to qualified performance -basedcompensation may be granted to any Eligible Grantee during any calendar year during the 162(m) Term. f.The Committee may provide in the Award Agreement that Awards under this Section 4.2(ix) shall be payable, in whole or in part, in the event of the Grantee’s death or Disability, or under other circumstances consistent with the Treasury regulations and rulings under Section 162(m) of the Code. 4.3 Change of Control of the Company. (i)The Committee may, at the time an Award is made or at any time prior to, coincident with or after the time of a Change of Control: a.provide for the adjustment of any Performance Goals as the Committee deems necessary or appropriate to reflect the Change of Control; b.provide for the cancellation of any Awards then outstanding if the surviving entity or acquiring entity (or the surviving or acquiring entity’s parent company) in the Change of Control replaces the Awards with new rights of substantially equivalent value, as determined by the Committee; c.provide that upon an involuntary termination of a Participant’s employment as a result of a Change of Control, any time periods shall accelerate, and any other conditions relating to the vesting, exercise, payment or distribution of an Award shall be waived; or d.provide that Awards shall be purchased for an amount of cash equal to the amount that could have been obtained for the shares covered by a Restricted Stock Award if it had been vested and or by an Option or SAR if it had been exercised at the time of the Change of Control. (ii)Notwithstanding any other provisions of the Plan or an Award Agreement to the contrary, the vesting, payment, purchase or distribution of an Award for any Grantee whose service to the Company has not terminated shall automatically be accelerated by reason of a Change of Control for any Grantee with respect to any outstanding grants. Further, unless otherwise provided by the applicable Award Agreement or determined by the Committee, any portion of an Award outstanding immediately prior to a Change of Control, the exercisability and/or vesting of such portion of the Award held by a Participant whose service to the Company has not terminated prior to Change in Control shall be accelerated in full effective as of a date prior to, but conditioned upon, the consummation of a Change in Control. 5 Operation 5.1 Duration. Grants may be made under the Plan through June 1, 2031. In the event of Plan termination while